Roxane Dilcher

Oct 15, 2024 | medrxiv.org | Roxane Dilcher |Charles B. Malpas |William O'Brien |Stuart Mcdonald

Conflict of Interest Disclosures: TOB reported receiving consulting fees to the institution from UCB, Livanova, GSK, and Eisai outside the submitted work. LV reported receiving consulting fees from Steminent Biotherapeutics outside the submitted work. No other disclosures were reported. ACTRN12620001254987This study was funded by a Medical Research Future Fund grant from the Australian Government to TOB and LV (MRF1200254).